Cellular and molecular basis of PfCoronin function in artemisinin resistance in Plasmodium falciparum Authors: Imran Ullah, Madeline A. Farringer, Malhar Khushu, Anna Y. Burkhard, Erica Hathaway, Bailey C. Willett, Sara H. Shin, Aabha I. Sharma, River Mallick, Eva S. Istvan, Morgan C. Martin, Oliver Harrigan, Kairon L. Shao, Jeffrey D. Dvorin, Daniel L. Hartl, Sarah K. Volkman, Selina Bopp, Sabrina Absalon, Dyann F. Wirth Published: 2026 ABSTRACT Artemisinin combination therapies are central to malaria control, but their efficacy is threatened by the emergence of resistant Plasmodium falciparum strains. While the role of Pfkelch13 mutations is well established, mutations in Pfcoronin have also been implicated in treatment failure, revealing layers of resistance complexity. Here, we define the cellular mechanism of Pfcoronin‑mediated artemisinin resistance. PfCoronin interacts with PfActin and localizes to the parasite plasma membrane, the digestive vacuole membrane, and small vesicles containing host cell material. Mutations in PfCoronin disrupt its localization and perturb PfActin homeostasis, altering the distribution of ring‑stage morphologies, including a reduced proportion of parasites adopting the cup‑shaped architecture. These changes are associated with decreased uptake of host cell contents by ring‑stage P. falciparum. Consistent with prior work on Pfkelch13 mutants, reduced hemoglobin uptake emerges as a feature of Pfcoronin‑mediated resistance. Although PfKelch13 and PfCoronin reside in distinct compartments and show no evidence of direct interaction, both influence endocytic access to hemoglobin. We propose that reduced hemoglobin uptake in ring‑stage parasites limits heme‑dependent activation of artemisinin and thus reduces its cytocidal activity. Our findings demonstrate that Pfcoronin mutations reduce endocytosis and modulate artemisinin susceptibility—highlighting how non‑essential, temporally restricted proteins can shape drug response and resistance. Introduction Rapidly acting and potent antimalarial drugs, such as artemisinin (ART) and others in its class, are critical components of current front-line treatments, and these drugs have contributed to yearly reductions in malaria mortality for the past two decades1. However, partial resistance to ART and artemisinin combination therapies (ACTs) threatens their efficacy2,3. ART treatment failures initially emerged in Southeast Asia, and were associated with mutations in the Plasmodium falciparum kelch13 locus4. The mechanism of Pfkelch13-mediated ART resistance is well studied, and prior work has demonstrated reduced hemoglobin uptake in ART-resistant Pfkelch13 mutant parasites5,6. ART is a sesquiterpene lactone with an endoperoxide bridge that must be cleaved to potentiate antimalarial activity. Typically, this activation occurs via heme7, likely derived via endocytosis and digestion of hemoglobin. Thus, the observed reduction in endocytosis in Pfkelch13 mutants may decrease the availability of free heme, slowing the activation of ART and leading to ART resistance5,6. As part of our previous efforts to understand potential ART-resistance mechanism(s) in Africa, we demonstrated Pfcoronin to be a major driver of in vitro partial ART resistance in Senegalese isolates of P. falciparum8,9. Coronin proteins are widely conserved, and while many organisms have multiple coronin genes, P. falciparum and other unicellular pathogens encode just one10,11. Like other Coronin orthologs, PfCoronin includes a WD40 domain. These domains are thought to facilitate protein-protein interactions and are involved in a wide range of cellular functions12,13. Coronin proteins have been associated with actin-binding activities in multiple organisms14; in the apicomplexan parasite, Toxoplasma gondii, TgCoronin regulates the rate and extent of actin polymerization, and is required for endocytosis and membrane recycling15. In P. berghei, PbCoronin is implicated in the regulation of gliding motility in sporozoites16. In P. falciparum, in vitro biochemical studies have confirmed that the WD40 domain of PfCoronin binds actin and organizes F-actin filaments into parallel bundles17. In late asexual blood-stage parasites, PfCoronin localizes to the parasite periphery, potentially linking actin filaments to the plasma membrane17; localization in earlier stages has not been previously assessed. Despite being considered non-essential for overall parasite viability, we hypothesized that Pfcoronin may nevertheless play a stage-specific and previously underappreciated role in drug response. Here, we systematically characterize PfCoronin’s molecular interactions in both ring-stage and late-stage parasites, and assess the impact of resistance-associated mutations on its abundance, subcellular localization, and involvement in hemoglobin uptake. In doing so, we seek to clarify how a non-essential, temporally restricted cytoskeletal regulator could serve as a critical mediator of ART resistance, and in turn, expand current perspectives on the molecular basis of parasite adaptation and therapeutic failure. Results Reduced interaction of PfCoronin mutants with PfActin in rings Previously, we demonstrated that mutations in the Pfcoronin gene are a major driver of in vitro evolved ART resistance in Senegalese isolates of P. falciparum, as measured by the ring-stage survival assay (RSA)8. Either a single G50E mutation (Senegalese isolate from Thiès) or paired R100K/E107V mutations (Senegalese isolate from Pikine) are sufficient to confer resistance8,9. PfCoronin contains a seven-bladed WD40 domain with Gly50 located in the first blade, and both Arg100 and Glu107 located in the second blade. We focused on the Pikine P. falciparum isolate in this study. WD40 domains have previously been associated with the facilitation of protein-protein interactions12,13. Therefore, to identify interaction partners of PfCoronin, we appended the spaghetti monster-human influenza hemagglutinin (HA) tag (smHA)18 to the c-terminus of the endogenous Pfcoronin locus in both PfcoroninWT and PfcoroninR100K/E107V parasites (Supplementary Fig. 1). We immunoprecipitated (IP) PfCoronin-smHA protein in both early ring and later trophozoite-stage parasites [3–9 or 32–40 h post-invasion (hpi)] using anti-HA antibodies; we also included an untagged PfcoroninWT control line. Co-purified proteins were identified by liquid chromatography with tandem mass spectrometry (LC-MS/MS). To identify potential PfCoronin interacting partners, we first filtered out proteins that were found in the untagged line and normalized prey protein abundance to that of PfCoronin bait abundance [(Supplementary Data 1 (3–9 hpi); Supplementary Data 2 (32–40 hpi)]. We established two criteria to prioritize top PfCoronin interacting partners: (1) the protein must be detected in all replicates of either PfCoroninWT-smHA or PfCoroninR100K/E107V-smHA parasites and (2) its abundance must be at least 5% of PfCoronin (bait) protein abundance. To investigate interactions that were potentially affected by mutations in Pfcoronin, we looked for differentially-associated proteins with, greater than 5x change in normalized abundance between PfCoroninWT-smHA and PfCoroninR100K/E107V-smHA, and/or for which the p-value (unpaired t-test between PfCoroninWT-smHA and PfCoroninR100K/E107V-smHA) was less than 0.05 [(Supplementary Fig. 2a and Supplementary Data 3 (3–9 hpi); Supplementary Fig. 2b and Supplementary Data 4 (32–40 hpi)]. Interestingly, in both stages, the major interacting partner of PfCoronin was PfActin (PF3D7_1246200; Fig. 1a, b), consistent with its previously-described role in regulating actin dynamics10,15,16,19,20. At ring stage, this interaction was reduced by three-fold in PfCoroninR100K/E107V-smHA parasites (p = 0.0113; Fig. 1a and Supplementary Fig. 2a; Supplementary Data 3); this reduction did not occur in the late-stage parasites (p = 0.4787; Fig. 1b and Supplementary Fig. 2b; Supplementary Data 4).Fig. 1Mutations in Pfcoronin alter PfActin homeostasis.a Immunoprecipitation of PfCoronin-smHA and associated proteins in ring-stage and b late trophozoite-stage parasites (bars show mean; n = 4 and n = 6 independent experiments for rings and trophozoites, respectively). c RSA survival (%) following 700 nM DHA pulse for 6-h increments at various points in the intraerythrocytic developmental cycle (mean ± SEM; n = 3 independent experiments). d Total PfActin levels in lysates from parasites expressing PfCoroninR100K/E107V-smHA (mutant) were compared by western blot to lysates from parasites expressing PfCoroninWT-smHA (representative blot shown). Blots were probed with anti-actin (mouse monoclonal; green) and anti-BiP (loading control; rabbit polyclonal, red) antibodies. Bar graph shows densitometric quantification of PfActin, normalized against PfBiP (mean ± SEM; n = 4 independent experiments for WT and n = 4 for mutant; ratio paired two-sided t-test, p = 0.0205). e EC50 values of JAS (WT and mutant each, mean ± SEM; n = 3 independent experiments per line; two-sided unpaired t-test with Welch’s correction, p = 0.3339). f Percent survival of parasites treated for 6 hours, starting at 3 hpi, with 740 nM JAS (mean ± SEM; n = 4 WT and n = 3 mutant independent experiments; paired two-sided t-test, p = 0.0026). Note that the DHA-selected Pikine parasite line carrying the R100K/E107V mutation in Pfcoronin was used for the RSA timecourse in c and JAS studies in (e) and (f). Source data are provided as a Source Data file. Mutations in Pfcoronin alter PfActin homeostasis. a Immunoprecipitation of PfCoronin-smHA and associated proteins in ring-stage and b late trophozoite-stage parasites (bars show mean; n = 4 and n = 6 independent experiments for rings and trophozoites, respectively). c RSA survival (%) following 700 nM DHA pulse for 6-h increments at various points in the intraerythrocytic developmental cycle (mean ± SEM; n = 3 independent experiments). d Total PfActin levels in lysates from parasites expressing PfCoroninR100K/E107V-smHA (mutant) were compared by western blot to lysates from parasites expressing PfCoroninWT-smHA (representative blot shown). Blots were probed with anti-actin (mouse monoclonal; green) and anti-BiP (loading control; rabbit polyclonal, red) antibodies. Bar graph shows densitometric quantification of PfActin, normalized against PfBiP (mean ± SEM; n = 4 independent experiments for WT and n = 4 for mutant; ratio paired two-sided t-test, p = 0.0205). e EC50 values of JAS (WT and mutant each, mean ± SEM; n = 3 independent experiments per line; two-sided unpaired t-test with Welch’s correction, p = 0.3339). f Percent survival of parasites treated for 6 hours, starting at 3 hpi, with 740 nM JAS (mean ± SEM; n = 4 WT and n = 3 mutant independent experiments; paired two-sided t-test, p = 0.0026). Note that the DHA-selected Pikine parasite line carrying the R100K/E107V mutation in Pfcoronin was used for the RSA timecourse in c and JAS studies in (e) and (f). Source data are provided as a Source Data file. Pfcoronin mutations only confer ART resistance in rings Overall, comparison between PfCoronin interaction partners in PfCoroninWT vs. PfCoroninR100K/E107V parasites showed far more differences at ring-stage than in late-stage parasites. Interestingly, this corresponds to the timing of ART clinical resistance, which manifests as delayed clearance of early ring-stage parasites. Additionally, Pfkelch13-mediated ART resistance in cultured parasites is only evident at the ring stage4,6. As a result, the ring-stage survival assay (RSA), where ring-stage parasites are exposed to physiological concentrations of dihydroartemisinin (DHA) for just 6 hours, has become the standard assay for in vitro ART resistance, with greater than 1% survival indicating ART resistance4. To assess whether Pfcoronin-mediated ART resistance is stage-specific, we treated parasites with 700 nM DHA for 6-hour pulses at various timepoints across development. Similarly to Pfkelch13 mutants, Pfcoronin-mediated artemisinin resistance is ring-stage specific: PfcoroninR100K/E107V mutants DHA selected PikineR line)8 did not show any resistance phenotype beyond 9 hpi (Fig. 1c). Pfcoronin mutations reduce PfActin protein levels in rings Since we observed reduced interactions with PfActin in PfcoroninR100K/E107V mutant ring-stage parasites, we were interested in whether these changes represented global differences in PfActin protein levels. We performed western blot analysis on ring-stage parasite lysates to assess whether PfActin abundance differs between PfCoroninWT-smHA and PfCoroninR100K/E107V-smHAmutant parasites. We found that PfCoroninR100K/E107V-smHA parasites contained 32.3 ± 5.79 % (mean ± SEM) less PfActin, compared to PfcoroninWT-smHA parasites in rings (p = 0.0205; Fig. 1d; see Supplementary Fig. 3a for full western blot images and additional examples). This decrease in PfActin protein levels is consistent with the reduced interactions with PfActin in PfCoroninR100K/E107V-smHA mutant ring-stage parasites; however, it is not clear how PfcoroninR100K/E107V mutations mediate these changes. We did not observe changes in PfActin protein levels in late-stage parasites (Supplementary Fig. 3b). Pfcoronin mutants sensitize PfActin to jasplakinolide Our data revealed that PfCoroninR100K/E107V-smHA parasites have changes in PfActin abundance. We therefore hypothesized that Pfcoronin mutations lead to defects or dysregulation of PfActin dynamics. We reasoned that these changes might alter sensitivity to jasplakinolide (JAS), which stabilizes PfActin filaments and promotes polymerization, ultimately disrupting normal PfActin dynamics. We tested this hypothesis using PfcoroninWT and PfcoroninR100K/E107V parasites (DHA selected Pikine_R line)8. We first estimated sensitivity to JAS using a standard 72 h growth assay and found no difference between PfcoroninWT (EC50 = 40.1 ± 1.3 nM) and PfcoroninR100K/E107V parasites (EC50 = 37 ± 2.6 nM; Fig. 1e and Supplementary Fig. 4). To assess possible differences in ring-stage parasites, we performed RSA-type assays on PfcoroninWT and PfcoroninR100K/E107V parasites. Parasites were treated for 6 hrs, starting at 3 hpi, with 740 nM JAS (~20X EC50). JAS had a modest effect on PfcoroninWT parasite survival (84 ± 9% survival) but significantly reduced the survival of PfcoroninR100K/E107V parasites (17 ± 6% survival) (Fig. 1f). Thus, Pfcoronin mutations sensitize parasites to PfActin disruptions, suggesting some level of underlying PfActin dysfunction or dysregulation, particularly in early ring-stage parasites. Pfcoronin mutations disrupt membrane localization in ring stages but not in late schizonts We used immunofluorescence assay (IFA) to investigate PfCoronin localization. Previous IFA studies17 have shown that PfCoronin is localized to the membrane of individual merozoites during late schizogony. Consistent with these studies, PfCoronin-smHA was localized to the merozoite membrane. We did not find any observable differences in localization of PfCoronin in PfCoroninWT-smHA vs. PfCoroninR100K/E107V-smHA late stage, segmenting parasites (Fig. 2a).Fig. 2Immunofluorescent characterization of PfCoronin.Super‑resolution fluorescence microscopy using a Zeiss LSM 980 with Airyscan 2 shows localization of PfCoronin. a Segmented schizonts. Representative segmented schizonts from PfCoroninWT‑smHA and PfCoroninR100K/E107V‑smHA parasites imaged by Airyscan super‑resolution microscopy. Columns show brightfield (ESID transmitted‑light detector, T‑PMT; grayscale), DNA (DAPI, blue), PfCoronin (yellow) and the merge. In both WT and mutant schizonts, PfCoronin decorates the periphery of individual merozoites as a rim‑like signal around each nucleus. Scale bar, 2 µm. b WT ring stages. Two independent PfCoroninWT‑smHA rings (top two rows) and a WGA‑labeled WT ring (bottom row). For each parasite, a single central optical section from an Airyscan Z‑stack is shown (plane of best‑focused DAPI). In both WT examples, PfCoronin is confined to a narrow peripheral zone at the parasite edge and appears as a complete or partial rim, with little signal in the parasite interior. The second WT example is shown as a higher‑magnification view centered on the PfCoronin signal to better illustrate the ring‑like labeling; as a result, only part of the low‑contrast erythrocyte cytosol is visible in the brightfield channel. In these brightfield images of ring‑stage parasites, intracellular rings can appear low in contrast or relatively dark compared with the surrounding erythrocyte cytoplasm, reflecting their small size and limited effect on transmitted‑light intensity in thin smears, as well as the marked dependence of brightfield contrast on smear thickness, focal plane, and the illumination, detector and display settings used during image acquisition. The corresponding brightfield/DAPI/PfCoronin Z‑stacks for these two WT rings are provided in Supplementary Figs. 5, 6. In the WGA panel, WGA (red) outlines RBCs, and the PfCoronin‑ and DAPI‑positive parasite lies within a single WGA‑positive RBC. Additional WGA‑labeled WT rings and their PfCoronin/WGA/DAPI Z‑stacks are shown in Supplementary Fig. 7a, b. Scale bars, 1 µm (first and third WT rows) and 0.5 µm (second WT row). c Mutant ring stages. A singly infected PfCoroninR100K/E107V‑smHA ring from the same synchronized preparation as the first WT example in panel (b) is shown. In the upper row (WT‑matched scaling), brightfield, DNA and PfCoronin are displayed with the same intensity settings as for the first WT ring in (b) (top WT row); under these conditions PfCoronin is not detectable at the parasite. In the bottom row, using a linear contrast stretch to visualize any residual signal (PfCoronin contrast‑stretched), only the PfCoronin display range is narrowed, while brightfield and DAPI are unchanged. With this stretch, weak scattered puncta become visible but remain at or near background level and do not form a peripheral rim or focus at the parasite. The corresponding brightfield/DAPI/PfCoronin Z‑stack for this mutant ring and a zoomed‑in Z‑stack of another mutant parasite are shown in Supplementary Figs. 8, 9. Scale bar, 1 µm. Panels (a–c) show representative images from at least three independent biological experiments. Immunofluorescent characterization of PfCoronin. Super‑resolution fluorescence microscopy using a Zeiss LSM 980 with Airyscan 2 shows localization of PfCoronin. a Segmented schizonts. Representative segmented schizonts from PfCoroninWT‑smHA and PfCoroninR100K/E107V‑smHA parasites imaged by Airyscan super‑resolution microscopy. Columns show brightfield (ESID transmitted‑light detector, T‑PMT; grayscale), DNA (DAPI, blue), PfCoronin (yellow) and the merge. In both WT and mutant schizonts, PfCoronin decorates the periphery of individual merozoites as a rim‑like signal around each nucleus. Scale bar, 2 µm. b WT ring stages. Two independent PfCoroninWT‑smHA rings (top two rows) and a WGA‑labeled WT ring (bottom row). For each parasite, a single central optical section from an Airyscan Z‑stack is shown (plane of best‑focused DAPI). In both WT examples, PfCoronin is confined to a narrow peripheral zone at the parasite edge and appears as a complete or partial rim, with little signal in the parasite interior. The second WT example is shown as a higher‑magnification view centered on the PfCoronin signal to better illustrate the ring‑like labeling; as a result, only part of the low‑contrast erythrocyte cytosol is visible in the brightfield channel. In these brightfield images of ring‑stage parasites, intracellular rings can appear low in contrast or relatively dark compared with the surrounding erythrocyte cytoplasm, reflecting their small size and limited effect on transmitted‑light intensity in thin smears, as well as the marked dependence of brightfield contrast on smear thickness, focal plane, and the illumination, detector and display settings used during image acquisition. The corresponding brightfield/DAPI/PfCoronin Z‑stacks for these two WT rings are provided in Supplementary Figs. 5, 6. In the WGA panel, WGA (red) outlines RBCs, and the PfCoronin‑ and DAPI‑positive parasite lies within a single WGA‑positive RBC. Additional WGA‑labeled WT rings and their PfCoronin/WGA/DAPI Z‑stacks are shown in Supplementary Fig. 7a, b. Scale bars, 1 µm (first and third WT rows) and 0.5 µm (second WT row). c Mutant ring stages. A singly infected PfCoroninR100K/E107V‑smHA ring from the same synchronized preparation as the first WT example in panel (b) is shown. In the upper row (WT‑matched scaling), brightfield, DNA and PfCoronin are displayed with the same intensity settings as for the first WT ring in (b) (top WT row); under these conditions PfCoronin is not detectable at the parasite. In the bottom row, using a linear contrast stretch to visualize any residual signal (PfCoronin contrast‑stretched), only the PfCoronin display range is narrowed, while brightfield and DAPI are unchanged. With this stretch, weak scattered puncta become visible but remain at or near background level and do not form a peripheral rim or focus at the parasite. The corresponding brightfield/DAPI/PfCoronin Z‑stack for this mutant ring and a zoomed‑in Z‑stack of another mutant parasite are shown in Supplementary Figs. 8, 9. Scale bar, 1 µm. Panels (a–c) show representative images from at least three independent biological experiments. We next compared localization of PfCoroninWT‑smHA and PfCoroninR100K/E107V‑smHA in ring‑stage parasites. In WT ring‑stage parasites, PfCoronin showed peripheral enrichment, consistent with association with parasite bounding membranes such as the PPM and/or parasitophorous vacuole membrane(PVM). In single confocal sections, PfCoronin appeared as a band surrounding the DAPI‑stained parasite nucleus (Fig. 2b, upper two rows). PfCoronin signal was strongest at the edge of the parasite, with comparatively lower fluorescence in the parasite interior, consistent with predominant peripheral localization in these stages. Confocal z‑stacks of individual ring‑stage parasites showed PfCoronin signal enriched along most of the parasite circumference in multiple consecutive optical sections, giving an overall ring‑like pattern at the parasite periphery, with weaker intraparasitic signal, rather than a single localized patch of fluorescence (Supplementary Fig. 5). To examine this distribution at higher spatial detail, we acquired higher‑magnification images centered on individual WT ring‑stage parasites (Fig. 2b, middle row; Supplementary Fig. 6). In these zoomed views, only a portion of the surrounding erythrocyte is captured because of the restricted field of view, but the reduced area resolves a relatively continuous PfCoronin band that closely follows the parasite outline and encircles the DAPI‑stained nucleus. To define the position of PfCoronin band relative to the host cell membrane, we co‑stained infected erythrocytes with wheat germ agglutinin (WGA) to label the red blood cell surface. In these preparations, the WGA signal outlined the erythrocyte boundary, whereas PfCoronin formed a ring around the parasite that was clearly positioned internal to the WGA‑positive membrane and encircled the DAPI‑stained nucleus (Fig. 2b, third row). A WGA/PfCoronin z‑stack and additional independent examples showed the same arrangement: a near‑circumferential PfCoronin band closely following the parasite outline and lying inside the host cell (Supplementary Fig. 7). Within the diffraction‑limited resolution of conventional confocal microscopy, these data therefore support enrichment of PfCoronin at the parasite periphery in ring‑stage parasites; however, given previous biochemical evidence that PfCoronin partitions between membrane‑associated and soluble pools in merozoites17, we do not interpret these images as excluding an additional low‑level cytosolic fraction. In the mutant line, peripheral PfCoronin signal at the ring stage was strongly diminished. When PfCoroninWT–smHA and PfCoroninR100K/E107V–smHA parasites were imaged under identical acquisition settings and displayed with the same contrast scaling, WT rings showed a clear peripheral PfCoronin band surrounding the DAPI‑stained nucleus (Fig. 2b), whereas PfCoronin was not detectable at the parasite periphery in the mutant (Fig. 2c, upper row). To assess whether a low‑level signal might still be present, we increased the display range for the mutant images. Upon contrast stretching, a faint PfCoronin signal became visible, with fluorescence distributed weakly around the parasite but lacking the bright, well‑defined peripheral band seen in WT (Fig. 2c, lower row). Consistent with this, z‑stacks of mutant ring‑stage parasites acquired under the same imaging conditions did not reveal a prominent peripheral PfCoronin band and only showed weak, diffuse fluorescence across optical sections even after contrast enhancement (Supplementary Fig. 8). As for WT, Supplementary Fig. 9 presents a higher‑magnification acquisition centered on a representative mutant parasite; in this view only part of the erythrocyte is visible, but the zoomed field makes evident that PfCoronin fluorescence is limited to weak, punctate signal and does not form a bright, continuous peripheral band. Together, these observations indicate that, if PfCoronin is present in mutant rings, its fluorescence is at or close to background and no longer forms a discernible peripheral enrichment, in contrast to the clear peripheral band observed in WT parasites. Because PfCoronin mutation is associated with altered PfActin homeostasis, we next examined PfActin localization in ring‑stage parasites using a P. falciparum–specific antibody that preferentially recognizes filamentous PfActin19 (Supplementary Fig. 10a). Consistent with previous work19, WT ring‑stage parasites frequently displayed peripheral F‑actin structures at the parasite boundary, including discrete F‑actin–rich puncta that were closely associated with PfCoronin signal. PfCoronin formed a continuous, well‑defined peripheral signal, and PfActin was enriched at the same perimeter, typically forming a ring‑like pattern that closely overlapped with PfCoronin, with local intensity variations that appeared as small puncta in some cells (Supplementary Fig. 10a). These differences were maintained in slightly older intraerythrocytic stages (Supplementary Fig. 10b). In WT parasites, PfCoronin was readily detected and formed a continuous, well-defined peripheral signal, with PfActin organized into dense puncta and short filament-like segments closely associated with PfCoronin, resulting in discrete regions of spatial overlap in merged images. In PfCoronin mutant parasites, PfCoronin- and PfActin-positive parasites were generally difficult to detect. When signal was observed, PfCoronin intensity was reduced, and PfActin appeared as scattered puncta and small aggregates with a more dispersed distribution and limited spatial overlap with PfCoronin. Together, these observations are consistent with Pfcoronin mutations being associated with altered F-actin assembly and/or maintenance, although these data do not distinguish between direct effects on PfActin polymerization and indirect effects mediated through altered PfCoronin stability or localization. This interpretation is supported by our pulldown, western blot, and JAS-treatment experiments (Fig. 1a, d, f), which collectively indicate perturbed PfActin homeostasis, although further work will be required to define the underlying mechanisms. The antibody used here preferentially recognizes filamentous PfActin19, but these filaments are short-lived and highly dynamic, making them difficult to visualize and quantify at the population level. Future studies employing episomal expression of PfActin chromobodies21 will be important to quantitatively assess PfActin filament organization and dynamics, and more precisely define the impact of Pfcoronin mutations. PfCoronin marks vesicular ultrastructures across development To gain further insights into PfCoronin localization, we performed ultrastructure expansion microscopy (U-ExM) imaging using Airyscan2 super-resolution microscopy22–24, assessing PfCoroninWT localization throughout development (Fig. 3). In ring-stage parasites, PfCoronin was enriched at the parasite periphery, likely representing PPM and/or parasite vacuolar membrane (PVM), with additional weaker intraparasitic puncta (Fig. 3). Further investigation in trophozoite stage parasites (26–34 hpi) showed localization of PfCoronin at the DV membrane and parasite periphery (Fig. 3). Occasionally, we observed PfCoronin-coated chains of small and large vacuoles (Supplementary Fig. 11a), possibly representing intermediates in vesicle trafficking to the DV. Co-staining with anti-aldolase showed that the contents of these vesicles are separated from the parasite cytoplasm, and a subset of small PfCoronin-labeled vesicles contained host cell–derived material (Supplementary Fig. 11b). To directly assess DV association, we generated dual-tagged parasites expressing PfCoronin-smHA and the DV marker chloroquine resistance transporter (CRT)-GFP and performed U-ExM analysis. PfCoronin showed colocalization with CRT at the DV membrane, supporting a role for PfCoronin in vesicular trafficking pathways that deliver host-derived material to the DV (Supplementary Fig. 12).Fig. 3Pfcoronin mutations impact localization.U-ExM shows PfCoronin-smHA WT and PfCoronin-smHA mutant localization throughout blood stage development. Alexa Fluor 405-conjugated NHS ester (protein density), HA (PfCoronin, yellow), Sytox deep red (DNA, Cyan). Images are maximum-intensity projections, number on image = Z-axis thickness of projection in µm. Images are representative of at least three independent biological experiments. Mut. mutant, Seg. segmented, DV digestive vacuole. PPM, parasite plasma membrane. Scale bars = 2 µm. Pfcoronin mutations impact localization. U-ExM shows PfCoronin-smHA WT and PfCoronin-smHA mutant localization throughout blood stage development. Alexa Fluor 405-conjugated NHS ester (protein density), HA (PfCoronin, yellow), Sytox deep red (DNA, Cyan). Images are maximum-intensity projections, number on image = Z-axis thickness of projection in µm. Images are representative of at least three independent biological experiments. Mut. mutant, Seg. segmented, DV digestive vacuole. PPM, parasite plasma membrane. Scale bars = 2 µm. Finally, in early schizonts, PfCoronin again localized to the parasite periphery and DV membrane. Interestingly, during these later stages, PfCoronin is also localized to small membrane-bound vacuoles (Fig. 3). These small vacuoles are located near the cytostome but do not overlap with it (Fig. 3). Cytostomes, double-membrane invaginations visible at the parasite periphery, are characterized by relatively small structures with a narrow neck connected to a wider body protruding into the parasite cytosol6,23,25. Notably, PfKelch13 localizes to the neck of the cytostome6,23,25. In our later-stage U-ExM localization, direct association between PfCoronin and the cytostomal body itself is not observed (Fig. 3). However, considering its presence at PPM/PVM, its involvement at the collar of the cytostome cannot be entirely ruled out. To test for possible colocalization with PfKelch13, we generated a dual-tagged parasite line expressing PfCoronin-smHA and PfKelch13-GFP. IFA showed that PfKelch13 localization was consistent with previous reports in both early and late stages26, but no colocalization with PfCoronin was detected (Supplementary Fig. 13). These observations are consistent with our pulldown experiments and previous reports showing no direct interaction between PfCoronin and PfKelch135,26, supporting a model in which these proteins act at spatially distinct, but potentially functionally convergent, steps of the endocytic pathway. Consistent with our U-ExM data, IFA of early schizonts revealed a similar localization pattern, with PfCoronin observed at the PPM/PVM, DV membrane, and smaller vesicles near the DV (Supplementary Fig. 14). PfCoronin mutations disrupt its ultrastructure localization and protein levels We next compared localization of PfCoroninWT-smHA vs. PfCoroninR100K/E107V-smHA using U-ExM. Interestingly, PfCoroninR100K/E107V formed disorganized puncta at earlier stages of development, including ring stage (Fig. 3; also see Fig. 2b for IFAs). We hypothesized that the disorganized punctate localization of PfCoroninR100K/E107V-smHA might be associated with reduced protein levels and therefore we performed immunoblot-based quantification analysis. We found significantly less PfCoronin protein in the PfCoroninR100K/E107V-smHA mutant than in PfCoroninWT-smHA WT ring-stage parasites (3–9 hpi), but protein levels were unchanged in late-stage parasites (32–40 hpi) (Fig. 4a, b; see Supplementary Fig. 15 for full western blot images and additional examples). In addition to BiP, aldolase was used as an extra loading control, further confirming a significant reduction in total PfCoronin protein levels in PfCoroninR100K/E107V-smHA compared to PfCoroninWT-smHA (p = 0.0054; Fig. 4c). No significant differences were observed in levels of BiP, aldolase, or GAPDH controls between PfCoroninWT-smHA WT and PfCoroninR100K/E107V-smHA mutant parasites (Fig. 4d). This result suggests that Pfcoronin mutations may specifically influence the stability of PfCoronin itself or its interacting partner, PfActin, without broadly impacting the proteome.Fig. 4PfCoronin mutations impact protein levels in ring-stage parasites.a Western blot analysis comparing total PfCoronin levels in lysates from late trophozoite-stage parasites expressing PfCoroninR100K/E107V-smHA (mutant) or PfCoroninWT-smHA (WT). Blots were probed with anti-HA (PfCoronin; mouse monoclonal; green) and anti-BiP (loading control; rabbit polyclonal; red). Bar graph shows PfCoronin band intensity normalized to BiP (mean ± SD; n = 4 independent experiments per line; ratio paired two-sided t-test, p = 0.887). b Western blot analysis comparing total PfCoronin levels in ring-stage parasites expressing PfCoroninR100K/E107V-smHA or PfCoroninWT-smHA. Blots were probed with anti-HA (PfCoronin; green) and anti-BiP (red). Bar graph shows PfCoronin band intensity normalized to BiP (mean ± SD; n = 7 independent experiments per line; ratio paired two-sided t-test, p = 0.0022). c Western blot analysis comparing total PfCoronin levels in ring-stage parasites expressing PfCoroninR100K/E107V-smHA or PfCoroninWT-smHA. Blots were probed with anti-HA (PfCoronin; green) and anti-aldolase (loading control; rabbit polyclonal; magenta). Bar graph shows PfCoronin band intensity normalized to aldolase (mean ± SD; n = 3 independent experiments per line; ratio paired two-sided t-test, p = 0.0054). Mut. mutant. d Western blot analysis of GAPDH, aldolase and BiP levels in ring-stage lysates from PfCoroninR100K/E107V-smHA and PfCoroninWT-smHA parasites (representative blots shown; anti-GAPDH, anti-aldolase, anti-BiP). Bar graphs show band intensities for each protein (mean ± SD; n = 3 independent experiments per line; ratio paired two-sided t-tests, GAPDH p = 0.4011, aldolase p = 0.7410, BiP p = 0.7259). Mut. mutant. Molecular weight markers (kDa) are indicated on all blots. Source data are provided as a Source Data file. PfCoronin mutations impact protein levels in ring-stage parasites. a Western blot analysis comparing total PfCoronin levels in lysates from late trophozoite-stage parasites expressing PfCoroninR100K/E107V-smHA (mutant) or PfCoroninWT-smHA (WT). Blots were probed with anti-HA (PfCoronin; mouse monoclonal; green) and anti-BiP (loading control; rabbit polyclonal; red). Bar graph shows PfCoronin band intensity normalized to BiP (mean ± SD; n = 4 independent experiments per line; ratio paired two-sided t-test, p = 0.887). b Western blot analysis comparing total PfCoronin levels in ring-stage parasites expressing PfCoroninR100K/E107V-smHA or PfCoroninWT-smHA. Blots were probed with anti-HA (PfCoronin; green) and anti-BiP (red). Bar graph shows PfCoronin band intensity normalized to BiP (mean ± SD; n = 7 independent experiments per line; ratio paired two-sided t-test, p = 0.0022). c Western blot analysis comparing total PfCoronin levels in ring-stage parasites expressing PfCoroninR100K/E107V-smHA or PfCoroninWT-smHA. Blots were probed with anti-HA (PfCoronin; green) and anti-aldolase (loading control; rabbit polyclonal; magenta). Bar graph shows PfCoronin band intensity normalized to aldolase (mean ± SD; n = 3 independent experiments per line; ratio paired two-sided t-test, p = 0.0054). Mut. mutant. d Western blot analysis of GAPDH, aldolase and BiP levels in ring-stage lysates from PfCoroninR100K/E107V-smHA and PfCoroninWT-smHA parasites (representative blots shown; anti-GAPDH, anti-aldolase, anti-BiP). Bar graphs show band intensities for each protein (mean ± SD; n = 3 independent experiments per line; ratio paired two-sided t-tests, GAPDH p = 0.4011, aldolase p = 0.7410, BiP p = 0.7259). Mut. mutant. Molecular weight markers (kDa) are indicated on all blots. Source data are provided as a Source Data file. Pfcoronin mutation do not affect ring-stage transition to trophozoites or overall asexual parasite development Our previous work established that Pfcoronin mutations do not significantly impair parasite growth9 over multiple cycles9. To assess whether the reduced abundance and altered localization of PfCoronin mutants influence parasite morphology or delay developmental progression, we conducted a time-course analysis on tightly synchronized parasites. First, to mirror the RSA experimental window, we examined parasite morphology every hour for the first 9 h post-invasion in both PfCoroninR100K/E107V-smHA and PfCoroninWT-smHA parasites. No discernible differences were observed between PfCoroninR100K/E107V-smHA mutant and PfCoroninWT-smHA WT parasites in ring-stage development (Fig. 5a). To assess whether PfCoroninR100K/E107V-smHA affects parasite cell‑cycle progression, DNA content was quantified by flow cytometry at 13 time points spanning 3–80 h post-invasion, with 200,000 events collected per line per time point and classified as 1n or >1n. The proportion of parasites with >1n DNA increased over time in both PfCoroninWT-smHA and PfCoroninR100K/E107V-smHA parasites, peaking at 54–60 hpi (Fig. 5b). Statistical comparisons at each time point using Welch’s t test with Holm–Šídák correction revealed no significant differences between PfCoroninWT-smHA and PfCoroninR100K/E107V-smHA parasites (p > 0.05 for all time points). Consistent with this, a mixed-effects model including WT/mutant status and time as fixed effects and biological replicate as a random effect confirmed that cell‑cycle progression, as measured by DNA content, increased significantly over time (p = 0.0071) but showed no effect of WT vs. mutant (p = 0.5242) and no WT/mutant × time interaction (p = 0.7373). These results indicate that Pfcoronin mutations do not alter cell‑cycle timing, overall developmental progression, or ring‑to‑trophozoite transition. We observed no detectable short‑term developmental arrest or delay within a single asexual cycle.Fig. 5PfCoronin mutations do not alter asexual blood-stage development.a Morphology of tightly synchronized (Percoll-purified) PfcoroninWT-smHA (WT) and PfCoroninR100K/E107V-smHA (mutant) parasites monitored every hour from 0 to 9 h post‑invasion (hpi) to mimic the RSA window. Giemsa‑stained thin blood smears show comparable ring‑stage morphology between WT and mutant parasites. Mut mutant; scale bar = 6 µm. Images are representative of three independent biological experiments. b Cell-cycle progression of PfcoroninWT-smHA (WT) and PfCoroninR100K/E107V-smHA (mutant) quantified by flow cytometry at 13 time points from 3 to 80 hpi. For each time point, 200,000 events per line were collected and classified as 1n or >1n DNA content. Differences between WT and mutant at each time point were assessed using two-sided Welch’s t tests with Holm–Šídák correction for multiple comparisons; all adjusted p-values were >0.05. A mixed-effects model including WT/mutant and time as fixed effects and biological replicate as a random effect confirmed a significant effect of time (two-sided test, p = 0.0071) but no effect of WT versus mutant (p = 0.5242) and no interaction between WT/mutant and time (p = 0.7373). Data are plotted as mean ± SD from three independent biological experiments. hpi, hours post invasion. Source data are provided as a Source Data file. PfCoronin mutations do not alter asexual blood-stage development. a Morphology of tightly synchronized (Percoll-purified) PfcoroninWT-smHA (WT) and PfCoroninR100K/E107V-smHA (mutant) parasites monitored every hour from 0 to 9 h post‑invasion (hpi) to mimic the RSA window. Giemsa‑stained thin blood smears show comparable ring‑stage morphology between WT and mutant parasites. Mut mutant; scale bar = 6 µm. Images are representative of three independent biological experiments. b Cell-cycle progression of PfcoroninWT-smHA (WT) and PfCoroninR100K/E107V-smHA (mutant) quantified by flow cytometry at 13 time points from 3 to 80 hpi. For each time point, 200,000 events per line were collected and classified as 1n or >1n DNA content. Differences between WT and mutant at each time point were assessed using two-sided Welch’s t tests with Holm–Šídák correction for multiple comparisons; all adjusted p-values were >0.05. A mixed-effects model including WT/mutant and time as fixed effects and biological replicate as a random effect confirmed a significant effect of time (two-sided test, p = 0.0071) but no effect of WT versus mutant (p = 0.5242) and no interaction between WT/mutant and time (p = 0.7373). Data are plotted as mean ± SD from three independent biological experiments. hpi, hours post invasion. Source data are provided as a Source Data file. Mutations in PfCoronin affect number of cup-shaped morphology in early rings As Giemsa staining and FACS-based analyses did not detect overt morphological differences, we examined young ring-stage parasites (3–9 h post-invasion) using U-ExM. Early ring-stage parasites typically adopt a cup-shaped morphology, characterized by a prominent central pit and PfCoronin-positive cortical shape, which is characteristic of this developmental window (Fig. 6a). We therefore assessed whether Pfcoronin mutations influence formation of this architectural state. U-ExM analysis of early ring-stage parasites (0–9 hpi) revealed a significant reduction in the fraction of parasites exhibiting a cup-shaped morphology in PfCoroninR100K/E107V-smHA parasites, with only 33% of parasites displaying this feature (Fisher’s exact test, p < 0.0001; Fig. 6b). In contrast, 81% of PfCoroninWT-smHA parasites adopted this architecture at the same stage. These data indicate that Pfcoronin mutations are associated with a shift in the distribution of early ring-stage cellular states, rather than a uniform defect in development.Fig. 6PfCoronin mutants display fewer cup-shaped rings and affect long-term fitness in competition assays.a Representative U-ExM images of PfCoronin-labeled cup-shaped parasites in PfcoroninWT-smHA (WT) and PfCoroninR100K/E107V-smHA (mutant) parasites. Alexa Fluor 405-conjugated NHS ester (protein density), HA (PfCoronin, yellow), Sytox Deep Red (DNA, cyan). Images are maximum-intensity projections, with the number on the image indicating the z-axis thickness of the projection in µm. Scale bars = 2 µm. Images are representative of five independent biological experiments. b Quantification of cup-shaped parasites at the early ring stage (≤9 h post-invasion, hpi) in PfcoroninWT-smHA and PfCoroninR100K/E107V-smHA parasites. Bars show the percentage of parasites with a cup shape, calculated from pooled counts across five independent biological experiments (WT: 51 of 63 rings; mutant: 14 of 42 rings). Statistical comparison was performed using a two-sided Fisher’s exact test (Baptista–Pike method), p < 0.0001. c Validation of allele-specific nanopore sequencing using control DNA mixes with known PfCoroninWT-smHA: PfCoroninR100K/E107V-smHA ratios (50:50, 100:0, 0:100). Observed allele frequencies closely match expected input ratios, confirming accurate allele discrimination and quantification. Bars showing SD from three independent biological replicates per DNA mix. d Long-term competition assay of PfCoroninWT-smHA and PfCoroninR100K/E107V-smHA parasites mixed at a 1:1 ratio and maintained under continuous culture for 60 days. Allele frequencies were measured by nanopore sequencing at days 0, 30 and 60. Data are shown as mean ± SD from three independent biological competition experiments. WT and mutant allele frequencies were compared at each time point using paired two-sided t-tests (day 0, p = 0.4396; day 30, p < 0.0001; day 60, p = 0.0010), revealing marked divergence at days 30 and 60. Source data are provided as a Source Data file. PfCoronin mutants display fewer cup-shaped rings and affect long-term fitness in competition assays. a Representative U-ExM images of PfCoronin-labeled cup-shaped parasites in PfcoroninWT-smHA (WT) and PfCoroninR100K/E107V-smHA (mutant) parasites. Alexa Fluor 405-conjugated NHS ester (protein density), HA (PfCoronin, yellow), Sytox Deep Red (DNA, cyan). Images are maximum-intensity projections, with the number on the image indicating the z-axis thickness of the projection in µm. Scale bars = 2 µm. Images are representative of five independent biological experiments. b Quantification of cup-shaped parasites at the early ring stage (≤9 h post-invasion, hpi) in PfcoroninWT-smHA and PfCoroninR100K/E107V-smHA parasites. Bars show the percentage of parasites with a cup shape, calculated from pooled counts across five independent biological experiments (WT: 51 of 63 rings; mutant: 14 of 42 rings). Statistical comparison was performed using a two-sided Fisher’s exact test (Baptista–Pike method), p < 0.0001. c Validation of allele-specific nanopore sequencing using control DNA mixes with known PfCoroninWT-smHA: PfCoroninR100K/E107V-smHA ratios (50:50, 100:0, 0:100). Observed allele frequencies closely match expected input ratios, confirming accurate allele discrimination and quantification. Bars showing SD from three independent biological replicates per DNA mix. d Long-term competition assay of PfCoroninWT-smHA and PfCoroninR100K/E107V-smHA parasites mixed at a 1:1 ratio and maintained under continuous culture for 60 days. Allele frequencies were measured by nanopore sequencing at days 0, 30 and 60. Data are shown as mean ± SD from three independent biological competition experiments. WT and mutant allele frequencies were compared at each time point using paired two-sided t-tests (day 0, p = 0.4396; day 30, p < 0.0001; day 60, p = 0.0010), revealing marked divergence at days 30 and 60. Source data are provided as a Source Data file. Pfcoronin mutations reduce parasite competitive fitness A decreased proportion of cup-shaped parasites was observed during early ring stages, although the functional significance of this heterogeneity is unclear (Fig. 6b). PfCoroninR100K/E107V-smHA parasites showed no detectable differences in cell cycle progression compared with PfCoroninWT-smHA. To determine whether Pfcoronin mutations influence population-level long-term fitness, we performed competition assays. PfCoroninWT-smHA and PfCoroninR100K/E107V-smHA parasites were mixed at a 1:1 ratio and maintained under continuous culture for 60 days. Relative allele abundance was monitored using allele-specific nanopore sequencing. Validation experiments using clonal and mixed control populations confirmed that the assay reliably discriminates alleles and accurately recovers expected ratios (Fig. 6c). Sampling at days 0, 30, and 60 revealed that while the initial ratio was approximately 50:50 at day 0, WT and mutant allele frequencies diverged markedly by days 30 and 60 (paired two-sided t-tests comparing WT and mutant allele frequencies at each time point; day 0, p = 0.4396; day 30, p < 0.0001; day 60, p = 0.0010), indicating a measurable competitive disadvantage of the PfCoroninR100K/E107V-smHA line (Fig. 6d). Although the precise mechanisms remain to be determined, these mutations may subtly compromise cellular processes, which do not overtly affect single-cycle development but cumulatively reduce replication efficiency over multiple generations. Such long-term disadvantages likely limit the spread of Pfcoronin mutations in natural parasite populations, consistent with the recent few reports, with one study linking Pfcoronin variants to parasite recrudescence27–30. Mutations in Pfcoronin reduce hemoglobin uptake Prior studies demonstrated that the uptake of RBC contents is decreased in ART-resistant Pfkelch13 mutants5,6. This reduction in endocytosis may slow the activation of ART by decreasing the availability of free heme. Given that ART activation depends on free heme produced via endocytic uptake of host hemoglobin, PfCoronin’s association with vesicular structures (Fig. 3, Supplementary Fig. 11b) led us to hypothesize that it may influence the endocytic pathway and thereby modulate ART susceptibility, particularly during the ring stage. To test this hypothesis, we performed a previously published microscopy-based endocytosis assay, using fluorescent-dextran as a tracer for uptake of host cell contents5. The assay was conducted in very young parasites, the stage at which ART resistance is evident. Briefly, fluorescein-dextran-loaded RBCs were mixed with late schizonts and incubated for 3 h to allow invasion. After 3 h, the remaining schizonts were removed by sorbitol synchronization. The resulting population of 0–3 hpi parasites were allowed to grow within the fluorescent-dextran-loaded RBCs for 6 h. Following this incubation, RBC cell contents were removed with saponin, leaving just the young parasites, which were fixed, and image analyses were performed5. Since Pfkelch13C580Y mutants had previously been assessed in the same assay6, we used Pfkelch13C580Y mutants9 to validate the assay. We measured a significant 34.6% reduction in fluorescent-dextran uptake in Pfkelch13C580Y mutant parasites compared to the PikineWT parent (unpaired Mann–Whitney test; p < 0.0001; Supplementary Fig. 16a; see Supplementary Fig. 16b–d for individual bioreps). This figure closely matches the 37.47% reduction previously reported in Pfkelch13C580Y mutants5. We then assessed fluorescent-dextran uptake in PfcoroninR100K/E107V mutants. Interestingly, we observed a 36.1% reduction in fluorescent-dextran uptake in PfcoroninR100K/E107V mutants compared to PfCoroninWT parasites (unpaired Mann–Whitney test; p < 0.0001; Fig. 7; see Supplementary Fig. 17).Fig. 7PfCoronin mutants decrease host cell content uptake.Comparison of internalized fluorescent dextran in PfcoroninWT-smHA (WT) and PfCoroninR100K/E107V-smHA (mutant) parasites, quantified by integrated density (vesicle size × intensity). Each data point represents fluorescent-dextran uptake by a single parasite (WT, n = 286 parasites; mutant, n = 286 parasites), pooled from the independent biological experiments shown in Supplementary Fig. 17. Black bars indicate mean ± SD. Statistical comparison between WT and mutant was performed using a two-sided unpaired nonparametric Mann–Whitney test, p < 0.0001. Non-smHA-tagged parasites, PfCoroninWT, PfCoroninR100K/E107V and PfKelch13C580Y (all in the Pikine background; see Supplementary Fig. 16 for PfKelch13), were included in these analyses. Source data are provided as a Source Data file. PfCoronin mutants decrease host cell content uptake. Comparison of internalized fluorescent dextran in PfcoroninWT-smHA (WT) and PfCoroninR100K/E107V-smHA (mutant) parasites, quantified by integrated density (vesicle size × intensity). Each data point represents fluorescent-dextran uptake by a single parasite (WT, n = 286 parasites; mutant, n = 286 parasites), pooled from the independent biological experiments shown in Supplementary Fig. 17. Black bars indicate mean ± SD. Statistical comparison between WT and mutant was performed using a two-sided unpaired nonparametric Mann–Whitney test, p < 0.0001. Non-smHA-tagged parasites, PfCoroninWT, PfCoroninR100K/E107V and PfKelch13C580Y (all in the Pikine background; see Supplementary Fig. 16 for PfKelch13), were included in these analyses. Source data are provided as a Source Data file. Together, these results reveal that the non-essential cytoskeletal regulator PfCoronin, while not required for asexual parasite growth, contributes to efficient hemoglobin uptake and optimal ART susceptibility at the clinically relevant ring stage. Mutations in Pfcoronin mimic the effects of Pfkelch13 variants by restricting endocytic access to host hemoglobin, thereby limiting heme-dependent drug activation. The distinct localization of PfCoronin points to engagement with parallel or downstream endocytic pathways, highlighting how non-essential, stage-specific parasite factors can be co-opted to diversify cellular strategies for therapeutic evasion and drug resistance. Discussion In this study, we show that PfCoronin has a stage-specific role in endocytic trafficking and ART susceptibility in P. falciparum. Resistance-associated Pfcoronin mutations (R100K/E107V) confer ART resistance selectively during the early ring stage, while later developmental stages are unaffected. These mutations perturb PfCoronin abundance, subcellular localization, and its association with PfActin only at the ring stage. Accompanying phenotypes—including decreased PfCoronin–PfActin interaction, reduced PfActin levels, and hypersensitivity to the actin-stabilizer JAS—are likewise limited to early rings. U-ExM analysis further reveals that WT PfCoronin is distributed at the PPM, DV, and vesicular compartments, but this organization is lost in mutant parasites, and is only restored in late schizogony. Functionally, Pfcoronin mutations reduce host hemoglobin uptake in rings—a phenotype also observed in Pfkelch13-mediated ART resistance5. Together, these findings establish that temporally restricted PfActin regulators can influence endocytic access to host resources and thus modulate drug response in malaria parasites. Distinctive features of P. falciparum endocytosis offer opportunities for selective therapeutic intervention. PfKelch13 localizes to the cytostome neck, and ART resistance–associated mutations in Pfkelch13 and interacting partners reduce hemoglobin uptake4,6,23,25,31,32. Unlike mammalian cells, where endocytosis is clathrin-dependent, the parasite cytostome was previously thought to lack clathrin but incorporates AP2-μ, highlighting evolutionary adaptations5. However, recent evidence33 implicating clathrin and AP1 in cytostome organization suggests this model may require refinement. Given these differences, understanding how additional regulators contribute to endocytosis and drug resistance remains critical. Our localization studies show that PfCoronin supports hemoglobin uptake from sites beyond the cytostome neck—specifically, at the PPM, DV, and vesicular compartments—suggesting a broader regulatory function. Although PfCoronin lacks canonical lipidation motifs or transmembrane domains, mammalian coronins associate with membranes via interactions with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)34. Consistent with this, biochemical fractionation in merozoites showed that PfCoronin partitions between a major soluble pool and a substantial carbonate‑extractable, PI(4,5)P2‑binding membrane‑associated fraction17. Our imaging refines this view by demonstrating that, in ring‑stage parasites, the brightest PfCoronin signal resides at parasite membranes, while weaker intraparasitic fluorescence indicates that an additional low‑level cytosolic pool cannot be excluded. PfCoronin localizes adjacent to the cytostome neck on the PPM, without overlapping the cytostomal body, suggesting it regulates PfActin dynamics downstream of vesicle formation. This likely coordinates PfActin-dependent vesicle transport during hemoglobin uptake, though alternative uptake pathways cannot be excluded. This role aligns with conserved coronin functions in other eukaryotes35,36. Notably, no direct physical association between PfCoronin and PfKelch13 was detected, either by IFA colocalization or biochemical pulldown, in agreement with previous reports5,26. Dual-tagged parasites expressing PfCoronin-smHA and PfKelch13-GFP confirmed that PfKelch13 retains its characteristic localization5,26, while PfCoronin occupies spatially adjacent but non-overlapping membrane domains. These findings support a model in which PfCoronin and PfKelch13 act at distinct yet potentially coordinated steps of hemoglobin uptake. Our previous genetic interaction analyses9 suggest functional crosstalk or partial compensation between these pathways, although the molecular basis remains unresolved. Actin cytoskeleton dynamics are central to endocytic processes in eukaryotes, facilitating vesicle trafficking and efficient nutrient acquisition37. In P. falciparum, stabilization of PfActin filaments disrupts cytostome architecture and hampers hemoglobin delivery to the DV38. These observations, together with our findings, support a close functional connection between cortical PfActin dynamics, endocytic vesicle trafficking, and hemoglobin transport to the DV—a process that has also been implicated in artemisinin activation39,40. We find that Pfcoronin mutations alter both PfActin abundance and its functional regulation, as evidenced by increased JAS sensitivity in ring stages. Consistent with these biochemical and pharmacological phenotypes, IFA analysis using a P. falciparum–specific antibody19 that preferentially recognizes filamentous PfActin revealed prominent peripheral F‑actin structures at the boundary of WT ring‑stage parasites. PfCoronin formed a continuous, well‑defined peripheral signal, and PfActin was enriched at the same perimeter, typically forming a ring‑like pattern that closely overlapped with PfCoronin. Local intensity variations were frequently observed as discrete, F‑actin–rich puncta at the parasite periphery, in agreement with previous reports19. In contrast, PfActin signal was rare in mutant parasites and, when detectable, appeared reduced and more diffuse, with a less clearly defined spatial organization and an apparent loss of the discrete peripheral puncta observed in WT parasites. These qualitative differences persisted into slightly later intraerythrocytic stages: WT parasites retained peripheral PfActin puncta that coalesced into denser patches and short filament-like segments, whereas mutant parasites displayed only occasional, scattered PfActin puncta throughout the cytosol. Together, these observations indicate impaired assembly and/or maintenance of peripheral F-actin structures during early development, consistent with our pulldown, western blot, and drug-sensitivity data. Apicomplexan actin filaments are short and highly dynamic41, and as widely recognized in the field, conventional antibodies—including those used in this study—cannot visualize filamentous PfActin at a population level, limiting quantitative interpretation of static images. Chromobody-based reporters21 enable live-cell, high-resolution visualization of PfActin filaments in their native context, and future application of these tools will be essential to directly define how PfCoronin regulates PfActin filament organization and dynamics during hemoglobin uptake. While the core trafficking machinery in P. falciparum is less understood than in model systems5,42–45, the parasite encodes a limited but specialized set of PfActin regulators, among which PfCoronin is notable for its regulatory role21,46–48. Beyond PfKelch13 and partners, relatively few proteins—including phosphoinositide-binding protein PX149, VPS4543, and the host enzyme peroxiredoxin 644—have been linked to endocytic trafficking. Our data highlight PfCoronin as an additional candidate in this restricted but functionally vital network. Together, our biochemical, pharmacological, and imaging data support a model in which resistance-associated Pfcoronin mutations (i) reduce PfCoronin–PfActin association and PfActin abundance at the ring stage, (ii) increase hypersensitivity to the actin-stabilizer jasplakinolide, and (iii) disrupt the organization of peripheral F-actin–rich regions where PfCoronin normally localizes. Although we cannot definitively distinguish whether the altered PfActin phenotype contributes directly to impaired hemoglobin uptake and ART susceptibility, or instead arises as a downstream consequence of Pfcoronin‑mediated changes in ring‑stage physiology, the stage restriction of the PfActin phenotype, its modulation by actin‑targeting compounds, and its consistent association with reduced hemoglobin uptake are all consistent with a functional role for PfCoronin‑dependent PfActin organization in endocytic trafficking. In light of prior evidence that stabilization of PfActin filaments disrupts endocytic membrane organization and hampers hemoglobin delivery to the DV38, our data suggest that PfCoronin‑mediated control of PfActin dynamics is likely to be an important determinant of how ring‑stage parasites internalize hemoglobin and respond to artemisinin. Further work integrating live‑cell PfActin reporters with stage‑resolved interaction mapping will be required to resolve this relationship at molecular detail. Taken together, these considerations support a model in which PfCoronin acts as a ring‑stage regulator of cortical/peripheral PfActin dynamics at parasite membranes, coordinating actin‑dependent vesicle trafficking required for hemoglobin uptake and thereby influencing artemisinin susceptibility. Resistance-associated Pfcoronin mutations do not cause a generalized defect in parasite development, as WT and mutant parasites progress indistinguishably through early ring morphology, the ring-to-trophozoite transition, and a complete asexual cycle with comparable timing of DNA replication and cell-cycle progression. Despite this normal progression, Pfcoronin mutations are associated with subtle changes in early ring-stage organization, including a reduced proportion of parasites exhibiting the characteristic cup-shaped morphology, reflecting increased heterogeneity within mutant populations. Although these alterations do not overtly impair single-cycle development, Pfcoronin mutant parasites display a measurable long-term competitive disadvantage over multiple generations. The relationship between early ring-stage heterogeneity and reduced fitness remains unresolved; nonetheless, these findings indicate that Pfcoronin mutations impose cumulative population-level costs not captured by short-term assays. Because the early ring stage coincides with hemoglobin uptake, endocytic trafficking, and the window of artemisinin susceptibility, such subtle cellular perturbations may contribute to a trade-off between drug resistance and long-term fitness that constrains the spread of Pfcoronin mutations. Mechanistically, resistance-associated Pfcoronin mutations selectively disrupt PfCoronin localization and reduce protein abundance during the ring stage, the period of maximal ART sensitivity. Localization is normalized in schizonts, indicating stage-specific disruption. In trophozoites, although overall PfCoronin abundance is comparable, mutants lack the spatial membrane association characteristic of WT parasites, indicating impaired recruitment or retention at functional sites. These observations suggest compensation by alternative cytoskeletal components in later stages. The basis for this stage-specific disruption remains unresolved. PfCoronin may depend on transient interactors—such as membrane adapters, lipid microdomains, or PfActin-associated proteins—that are preferentially expressed or active during ring and later stages. Alternatively, resistance-associated mutations may alter PfCoronin conformation, selectively impairing its function under the highly dynamic trafficking conditions of early development. Our current interactome approaches likely under-detect transient or low-abundance interactions. Stage-resolved proximity-labeling strategies will be essential to define PfCoronin’s dynamic interaction network and to elucidate how resistance-associated mutations rewire cytoskeletal and trafficking pathways. Collectively, our data demonstrate that PfCoronin exerts a ring-stage-restricted regulatory role in vesicular trafficking that modulates ART susceptibility without affecting parasite viability. This underscores how proteins classified as non-essential can nevertheless perform critical, temporally confined functions within drug response networks. Clinically, the recent identification of Pfcoronin mutations in clinical isolates—including R100K27–30 and other novel mutations detected in ACT-treated patients in Nigeria29, which were associated with delayed parasite clearance—underscores the relevance of these ring-stage regulators in treatment failure and emphasizes the need for surveillance strategies that extend beyond canonical resistance loci. Adaptations in cytoskeletal and endocytic pathways represent an underappreciated axis of resistance evolution, and reassessing gene essentiality through a developmental lens will be critical for anticipating emergent drug resistance. In summary, PfCoronin exemplifies how stage-restricted cytoskeletal regulators orchestrate the interface between host resource acquisition and antimalarial drug susceptibility. PfCoronin acts as a molecular organizer whose dysfunction—rather than simple absence—undermines hemoglobin uptake and drug response. This highlights the complexity of ring-stage biology, where proteins dispensable for overall survival can nonetheless exert outsized effects on specific cellular processes and drug sensitivity through stage-specific interaction networks. As ART remains central to global malaria treatment, ongoing mechanistic studies and field genetic surveillance of Pfcoronin—and other adaptive regulators—will be essential for effective malaria control and strategies to anticipate evolving drug resistance. Methods Parasite culture P. falciparum culture-adapted field isolates, Pikine (SenP019.04), Pikine_R (DHA selected line8), CRISPR-engineered Pikine PfcoroninR100K/E107V mutant (CRISPR-edited), Pfkelch13C580Y mutant (CRISPR-edited)8,9, spaghetti monster HA tag (smHA)-tagged Pikine PfcoroninWT-smHA, and Pikine PfcoroninR100K/E107V-smHA mutant lines were maintained in complete RPMI 1640 medium (Gibco) supplemented with 10% O+ serum at 4% hematocrit (unless specified otherwise) in an atmosphere of 1% O2, 5% CO2, and 94% N2 at 37 °C8,9. The parasite lines used in this study are summarized in Table 1. All smHA-tagged lines were additionally cultured with 5 nM WR99210 (Jacobus Pharmaceutical). Staging and parasitemia were assessed by light microscopy of Giemsa-stained thin blood smears50,51. The parasites were synchronized using sequential sorbitol lysis treatment52.Table 1P. falciparum Pikine-derived parasite lines used in this studyParasite lineGenetic backgroundDetailsSNP(s) in Pfcoronin or Pfkelch13smHA-taggedPurpose in studyPikine parent (SenP019.04)PikineCulture-adapted P. falciparum line from SenegalNoNoUsed for RSA timecourse, JAS survival experiments, and endocytosis experimentsPikineRPikineIn vitro evolved ART resistant linePfcoronin R100K/E107VNoUsed for RSA timecourse and JAS survival experimentsPfcoroninR100K/E107V mutantPikineCRISPR-edited line (cF5)Pfcoronin (R100K/E107V)NoUsed for endocytosis experimentsPfKelch13C580YPikineCRISPR-edited linePfkelch13 (C580Y)NoUsed for endocytosis experimentsPfCoroninWT-smHAPikineCRISPR-edited lineNoYesUsed in all experiments reported in this manuscriptPfCoroninR100K/E107V-smHAPikineCRISPR-edited line (cF5)Pfcoronin (R100K/E107V)YesUsed in all experiments reported in this manuscriptSummary of parental, in vitro–evolved and CRISPR-edited lines, indicating Pfcoronin/Pfkelch13 polymorphisms, smHA tagging and primary experimental application Table 1P. falciparum Pikine-derived parasite lines used in this studyParasite lineGenetic backgroundDetailsSNP(s) in Pfcoronin or Pfkelch13smHA-taggedPurpose in studyPikine parent (SenP019.04)PikineCulture-adapted P. falciparum line from SenegalNoNoUsed for RSA timecourse, JAS survival experiments, and endocytosis experimentsPikineRPikineIn vitro evolved ART resistant linePfcoronin R100K/E107VNoUsed for RSA timecourse and JAS survival experimentsPfcoroninR100K/E107V mutantPikineCRISPR-edited line (cF5)Pfcoronin (R100K/E107V)NoUsed for endocytosis experimentsPfKelch13C580YPikineCRISPR-edited linePfkelch13 (C580Y)NoUsed for endocytosis experimentsPfCoroninWT-smHAPikineCRISPR-edited lineNoYesUsed in all experiments reported in this manuscriptPfCoroninR100K/E107V-smHAPikineCRISPR-edited line (cF5)Pfcoronin (R100K/E107V)YesUsed in all experiments reported in this manuscriptSummary of parental, in vitro–evolved and CRISPR-edited lines, indicating Pfcoronin/Pfkelch13 polymorphisms, smHA tagging and primary experimental application P. falciparum Pikine-derived parasite lines used in this study Summary of parental, in vitro–evolved and CRISPR-edited lines, indicating Pfcoronin/Pfkelch13 polymorphisms, smHA tagging and primary experimental application Generation of smHA-tagged parasites and transfection Pfcoronin (PF3D7_1251200) was tagged with smHA using CRISPR/Cas9. The CRISPR guide sequence (selected using benchling.com) was 5’-AATGTGTAAAAGTACAGCAA-3’, which matches a site near the C-terminus of the PfCoronin coding sequence. A double-stranded DNA segment with “sticky ends” was generated by annealing oligonucleotides 5’-ATTGAATGTGTAAAAGTACAGCAA-3’ and 5’-AAACTTGCTGTACTTTTACACATT-3’. This segment was ligated within the U6 cassette of pBAM20353 (pre-digested with BbsI; kind gift of Dr. Jeffrey Dvorin, Harvard Medical School), proximal to the invariable part of the chimeric sgRNA scaffold, to generate pUF1-Cas9-hDHODH-Coronin. The donor/homologous repair plasmid for smHA-tagging PfCoronin was derived from pSAB5523 (kind gift of Dr. Jeffrey Dvorin, Harvard Medical School), which contains coding sequence for spaghetti monster-HA tag (smHA), followed by the PfHSP86 3’ UTR. Additionally, the plasmid includes a cassette for expression of human dihydrofolate reductase (hDHFR), allowing selection using WR99210. A 5’ homology arm (plus shield mutations) was amplified from the end (C-terminus) of the PfCoronin coding sequence using primers: 5’-CAATTGCCATGGGACAGTTTACCAAAAAATTTACCTTC-3’ and 5’-ATCTCGAGTAAAACGGTTGCAGTACTTTTACACATTTTCATGTCTAG-3’; the second primer includes shield mutations to protect from cutting by Cas9. This segment was inserted into the NcoI/XhoI sites of pSAB55. A 3’ homology arm was amplified from the PfCoronin 3’ UTR using 5’- CGTCAGGATCATCGCGGCCGCGGCACATCAGCGATCAC-3’ and 5’-CATGGCAATTGAGATCTCCGAAAAATTTGTATGATATTGAAAAG-3’; this segment was inserted into the NotI/BglII sites of the plasmid using Gibson cloning, generating pSAB55-Coronin-smHA. Prior to transfection, the complete pSAB55-Coronin-smHA plasmid was linearized by digestion with NcoI. Plasmids (50 µg each of pUF1-Cas9-hDHODH-Coronin and linearized pSAB55-Coronin-smHA) were transfected into Pikine parasites carrying either PfCoroninWT (WT) or PfCoroninR100K/E107V, as reported previously9. Transfections were performed as described previously9,54. Transfected parasites were allowed to recover overnight before the addition of 5 nM WR99210 (selection agent for pSAB55-Coronin-smHA) and 500 nM DSM1 (selection agent for pUF1-Cas9-hDHODH-Coronin). Drug selection with DSM1 was continued for 3 days. Parasites grew up around 3 weeks and were cloned by limiting dilutions prior to studies. Confirmation of the smHA-tagged parasites is detailed in Supplementary Fig. 1. Generation of dual-tagged P. falciparum lines PfCRT–GFP and GFP–PfKelch13 parasite lines were generated as described below and subsequently used as the parental backgrounds for C-terminal smHA tagging of PfCoronin to generate dual-tagged parasite lines. For generation of PfCRT–GFP parasites, the crt open reading frame was amplified from 3D7 cDNA using primers CRT-1 and CRT-2 (CRT-1:CGAATAAACACGATTTTTTCTCGAGATGAAATTCGCAAGTAAAAAAAATAATCAAAAAAATTC; CRT-2: CATAATGTGCTGCACCTGGCCTAGGTTGTGTAATAATTGAATCGACGTTGGTTAATTCTCCTTC), which introduce XhoI and AvrII restriction sites, respectively. The PCR product was cloned into the EOE-2xattP vector55 by In-Fusion cloning using the XhoI and AvrII sites. NF54:attB parasites were transfected with 100 µg of the PfCRT–GFP plasmid and 50 µg of the pINT integrase plasmid and selected with 2 µM DSM1. For generation of GFP– PfKelch13 parasites, the kelch13 open reading frame was amplified from 3D7 genomic DNA using primers Kelch-1 and Kelch-2 (Kelch-1: GAACTGTACAAACACGAGATCGAGATGGAAGGAGAAAAAGTAAAAACAAAAGC; Kelch-2: CGTCCTTGTAGTCCCTAGGTTATATATTTGCTATTAAAACGGAGTG), which introduce XhoI and AvrII restriction sites, respectively. The PCR product was cloned by In-Fusion cloning into the GFP-pTEOE vector using the XhoI and AvrII sites. GFP-pTEOE is a modified version of pTEOE56, with GFP inserted at the XhoI site and expressing yDHOD as a selectable marker. 3D7 parasites were transfected with 100 µg of the GFP–PfKelch13 plasmid and 50 µg of the PiggyBac transposase plasmid (MRA-912) and selected with 2 µM DSM1. PfCoronin-smHA was subsequently introduced into the PfCRT–GFP and GFP–PfKelch13 parasite lines using CRISPR/Cas9 as described above, generating dual-tagged parasite lines. Plasmids and parasite lines generated in this study are available from the corresponding authors on request. Ring stage survival assay (RSA) Standard ring‑stage survival assays (RSA) were performed using established protocols4,8,9,57 as follows. P. falciparum cultures at the late segmented schizont stage were purified using the Percoll gradient and allowed to reinvade for 3 h before subjecting them to synchronization. Highly synchronized (0–3 h post-invasion) parasites were pulsed with 700 nM DHA (Sigma-Aldrich) or 740 nM jasplakinolide (ref. no. 420127, Sigma-Aldrich), or DMSO control. The pulse was followed by drug washout and further incubation at 37 °C for 66 h, and parasitemia was assessed by light microscopy of Giemsa-stained thin blood smears8,9. RSA survival rates in percentage were estimated by comparing the survival of viable parasites to the untreated DMSO control for the same parasite line. Smears were blinded, and 10,000 RBCs were counted for each condition. Unless otherwise specified, all experiments used at least three independent biological replicates and two technical replicates. Concentration–response assays All EC50s were estimated using the standard 72 h Malaria SYBR green I fluorescence assay58,59. Ring-stage parasites (40 μL, 1% hematocrit and 1% starting parasitemia, n = 3) were cultured for 72 hours at 37 °C in a 384-well black clear-bottom plates containing 12-point serial dilutions of test compounds, 10 μM DHA kill-control and no drug growth-control. Lysis buffer containing 16% w/v saponin, 1.6% Triton X-100, 5 mM EDTA, 20 mM Tris-HCl, pH 7.4) and 1x SYBR Green I fluorescent dye (CAT. No. S7563, Invitrogen) was added, and the plates were incubated at room temperature in the dark for at least 6 h prior to reading. The fluorescent signal was measured using SpectraMax M5 (Molecular Devices, Sunnyvale, CA) plate reader (excitation at 494 nm, emission at 530 nm). Experiments were carried out as three technical triplicates on the same plate, with three independent biological repeats of each plate performed. Controls in each biological replicate consisted of parasite culture with no drug added (100%) or 10 μM DHA kill-control (0%). The mean and SD of fluorescence data from three independent biological repeats were expressed as a proportion of the untreated control (100%) and calculated as follows: 100 × [μ(S) − μ(−)/μ(+) − μ(−)], where μ(S), μ(+) and μ(−) represent the means for the sample in question and 100% and 0% controls, respectively51,60. The percentage growth was plotted against log10-transformed drug concentration and EC50s were estimated using a non-linear regression (log(inhibitor) vs response-variable slope with four parameters) in GraphPad Prism (GraphPad Software, Inc., San Diego, CA, USA). Values from the three biological replicates were used to calculate the mean EC50 values ± SE shown. Co-immunoprecipitation For co-immunoprecipitation, (Co-IP) experiments, tightly synchronized (with 5% D-sorbitol52 and density centrifugation with Percoll) parasites were used. A total of 4 × 109 (32–40 hpi, for late stages) or 4 × 109 (3–9 hpi, for ring stages) parasites were harvested by washing with PBS, and then the RBCs were lysed with 0.05% saponin in PBS in the presence of EDTA-free complete mini protease inhibitors (CAT. No. 4693159001, Sigma). The samples were then washed with PBS supplemented with protease inhibitors cocktail to remove residual RBC material. Parasite extracts were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, and EDTA-free complete mini protease inhibitors) by incubating the samples on a rotator for 1 h at room temperature. The samples were then sonicated three times at 20% amplitude for 30 s at 4 °C with 3-min rests on ice to chill the samples. The soluble fractions were collected by spinning the samples 12,000 × g for 30 min and incubated with 40 μL anti-HA magnetic beads (ref no 88836, Pierce) overnight at 4 °C. Beads were washed three times with RIPA in the presence of protease inhibitor cocktail, each time with a 10-min incubation at RT on a rotator. The beads were subsequently washed once each with buffer 1 (2% SDS in dH2O), buffer 2 (50 mM HEPES, pH 7.5, 500 mM NaCl, 1 mM EDTA, 1% TritonX-100 and 0.1% sodium deoxycholate in dH2O) and buffer 3 (10 mM Tris-HCl pH 8.0, 250 mM lithium chloride, 1 mM EDTA, 0.5% NP-40 and 0.5% sodium deoxycholate in dH2O). The beads were then washed at least six times with buffer 4 (50 mM ammonium bicarbonate in dH20), and resuspended in 40 μL of 5 mM ammonium bicarbonate. Then, 200 ng/µL of modified sequencing-grade trypsin (Promega, Madison, WI) was spiked in and the samples were incubated overnight at 37 °C. The samples were then placed on a magnetic plate, and the liquid was removed. The extracts were then dried in a speed-vac (~1 h). Samples were then re-suspended in 50 µL of high-performance liquid chromatography (HPLC) solvent-A (2.5% acetonitrile, 0.1% formic acid) and desalted by STAGE tip61. On the day of analysis, the samples were reconstituted in 10 µL of HPLC solvent-A. A nano-scale reverse-phase HPLC capillary column was created by packing 2.6 µm C18 spherical silica beads into a fused silica capillary (100 µm inner diameter, ~30 cm length) with a flame-drawn tip62. After equilibrating the column, each sample was loaded via a Famos autosampler (LC Packings, San Francisco CA) onto the column. A gradient was formed, and peptides were eluted with increasing concentrations of solvent-B (97.5% acetonitrile, 0.1% formic acid). As peptides eluted, they were subjected to electrospray ionization and then entered into an LTQ Orbitrap Velos Elite ion-trap mass spectrometer (Thermo Fisher Scientific, Waltham, MA). Peptides were detected, isolated, and fragmented to produce a tandem mass spectrum of specific fragment ions for each peptide. Peptide sequences (and hence protein identity) were determined by matching protein databases with the acquired fragmentation pattern by the software program, Sequest (Thermo Fisher Scientific, Waltham, MA)63. All databases include a reversed version of all the sequences and the data was filtered to between a one and two percent peptide false discovery rate. Immunoblotting Synchronized parasites were isolated on ice for 10 minutes with 0.015% saponin. Isolated parasites were washed three times with ice-cold PBS containing a protease inhibitor cocktail (Roche cOmplete mini, Sigma Cat. No. 11836153001) before lysis in 1x Laemmli Sample Buffer (Biorad Cat. No. 1610747) containing 5% beta-mercaptoethanol, followed by heating the samples at 99 °C for 10 minutes. Protein samples were separated on Mini-PROTEAN® TGX™ Precast Gels (4–20% gradient, BioRad Cat. No. 4561091) in Tris-SDS-glycine buffer. Separated proteins were transferred to a nitrocellulose membrane (Life Technologies Cat. No. IB3010-31) using an iBlot system (Life Technologies). The membrane was blocked in Intercept® (TBS) Blocking Buffer (LI-COR Biosciences Cat. No. 927-60001) for 1 h at room temperature on an orbital shaker. Membrane-bound proteins were first probed with primary antibodies [mouse anti-PfActin 5H3 (1:100; Walter and Eliza Hall Institute of Medical Research Cat. No. 26/11-5H3-1-2)19, mouse anti-HA (1:2000; Pierce Cat. No. 26183), rabbit anti-aldolase (1:5000; Abcam Cat. No. ab207494), Anti-GAPDH (P. falciparum) Antibody, clone 1.4 (1:1000; Sigma Cat. NO. MABS1946) or rabbit polyclonal anti-BiP (1:5000; kindly gifted by Dr. Jeffrey Dvorin, Harvard Medical School)] in Intercept® (TBS) with 0.2% Tween 20 at 4 °C overnight. The membranes were then incubated for 45 min at room temperature with secondary antibodies [IRDye® 680RD goat anti-mouse (1:10,000; LI-COR Biosciences Cat No. 926-68070) and IRDye® 800CW Goat anti-Rabbit (1:10,000; LI-COR Biosciences Cat. No. 926-32211)], washed, and imaged, then analyzed using the LI-COR Odyssey CLx Imager System (LI-COR Biosciences). Microscopy-based endocytosis assay (ring-stage) RBCs were suspended in a hypotonic solution and pre-loaded with fluorescent-dextran (Alexa 488; ThermoFisher Cat. No. D22910)6,43. After resealing red blood cells (RBCs) and trapping fluorescent dextran within, schizonts were added and allowed to re-invade by following the RSA setup. As the parasites (rings) grew within the fluorescent-dextran-containing RBCs, fluorescent-dextran was endocytosed and accumulated in the DV or other compartments. The parasites were then treated with 5% sorbitol to remove any remaining schizonts, closely mimicking the RSA setup. Parasites were washed once with RPMI medium and released from the RBCs using 10 pellet volumes of PBS containing 0.015% saponin. Following 3 washes with RPMI medium, parasite samples were fixed with pre-warmed 4% paraformaldehyde-0.1% glutaraldehyde in PBS for 20 min at 37 °C. Afterwards, 2–5 µL samples were loaded onto clear slides, covered with a coverslip, and allowed to settle for up to 15 min at room temperature before imaging. DIC and AF488 channel images were captured using a 100X oil immersion objective on a Zeiss Axio Observer. AF488 channel images were acquired at 480 ms across all samples, with a laser intensity of 40%. Images were blinded prior to analysis. Analysis was conducted for regions of interest (ROIs) where an RBC ghost could be visualized around a green channel signal in the merged image. A global threshold was set on 8-bit images of the green channel across images taken at the same exposure settings. Area, mean gray value, and integrated density of the parasite-specific green-channel signal were measured using ImageJ (https://imagej.net/ij/). Immunofluorescence assay Late-stage parasites were settled on to a poly-D-lysine coated #1.5 12 mm coverslip for 30 min. After removing the supernatant, the parasites were fixed with 4% paraformaldehyde for 10 min, then washed 3 times in PBS. Cells were permeabilized with 0.1% Triton X-100 in PBS for 10 min and washed three times in PBS for 3 min. Blocking solution (3% (w/v) BSA in PBS) was added and samples were incubated overnight at 4 °C. Primary antibodies were diluted in blocking solution and added to the coverslips for 2 h at room temperature. Coverslips were washed 3 times for 3 min in PBS and then incubated with secondary antibody in blocking solution for 45 min. Coverslips were washed three times with PBS, then mounted onto a slide with VectaShield Vibrance with DAPI. Parasites were visualized on a Zeiss LSM980 with Airyscan2 for super-resolution microscopy. A 63× objective with a numerical aperture of 1.4 was used. Primary rat anti-HA antibody was used at 1:200 (3F10 rat anti-HA, 1867423001 Sigma). For Ring stage IFAs, thin blood smears were prepared on glass slides and air-dried. Smears were fixed in 4% (w/v) paraformaldehyde in PBS for 10 min at room temperature and washed three times with PBS. Cells were permeabilized with 0.1% (v/v) Triton X-100 in PBS for 10 min and washed three times with PBS (3 min each). Samples were blocked in 3% (w/v) BSA in PBS for 1 h at room temperature. Primary antibodies diluted in blocking solution were applied overnight at 4 °C (rabbit anti-HA, 1:200; RM305, SAB5600116, Sigma-Aldrich; mouse anti-PfActin 5H3, 1:100; Walter and Eliza Hall Institute of Medical Research, cat. no. 26/11-5H3-1-219). Slides were washed three times with PBS and incubated with secondary antibodies for 45 min at room temperature. Where indicated, wheat germ agglutinin (WGA; 1:1000 from a 2 mg ml–1 stock, 29022–1, Biotium, to stain the RBC membrane) was included during the secondary antibody incubation64. DNA was stained with Hoechst prior to mounting. Slides were washed three times with PBS and mounted using VectaShield mounting medium without DAPI (Vector Laboratories). Late-stage and ring-stage IFAs used for comparison between WT and mutant were imaged on a Zeiss LSM 980 equipped with Airyscan2 using a 63× oil-immersion objective. Fluorescence images were acquired using the Airyscan detector. Brightfield images were acquired in parallel using the ESID transmitted‑light detector (T‑PMT) to visualize erythrocyte morphology and parasite position. In these transmitted-light images, intracellular parasites can appear low in contrast or relatively dark compared with the surrounding erythrocyte cytoplasm. This reflects the small size of early rings and their limited effect on transmitted-light intensity in thin smears, as well as the marked dependence of brightfield contrast on smear thickness, focal plane, and the illumination, detector and display settings used during image acquisition. Ring-stage PfCoronin colocalization IFAs (PfCoronin-smHA–PfActin, PfCoronin-smHA–WGA and PfCoronin-smHA–GFP-PfKelch13) were performed on thin blood smears as described above. Imaging was carried out on a separate Zeiss LSM 980 equipped with an Airyscan detector using a 63× oil-immersion objective. Fluorescence images were acquired using the Airyscan detector. Transmitted‑light imaging (ESID/T‑PMT) was not available on this system and was therefore not acquired. FACS analysis for cell cycle progression WT and mutant parasites were Percoll-purified and synchronized at 3 h post-invasion. Samples were collected every 6 h to monitor cell cycle progression. As described previously65, parasites were stained with 10× SYBR Green I in 1× PBS for 30 min at 37 °C in the dark, then washed and resuspended in 1x PBS. Data acquisition was performed on a MACSQuant VYB (Miltenyi Biotec) using the manufacturer’s acquisition software with a 488 nm laser and a 525 nm emission filter. RBCs were gated based on forward and side scatter, and infected RBCs were detected in channel B1. At least 200,000 events per sample were acquired and analyzed using FlowJo v2 to determine parasite DNA content and cell cycle distribution. Experiments were performed in three biological replicates. Long-term competitive fitness assay with nanopore sequencing WT and mutant parasites were mixed at a 1:1 ratio, maintained under standard culture conditions over 60 days, and samples were collected at defined intervals to monitor long-term changes in relative abundance. DNA from each sample was amplified at the locus of interest and submitted to Plasmidsaurus for Oxford Nanopore sequencing. The relative frequencies of WT and mutant alleles were quantified at each time point, and changes in allele frequency over time were used to calculate competitive fitness. Experiments were performed in at least three biological replicates. Ultrastructure expansion microscopy (U-ExM) Late segmented schizont stage PfCoroninWT-smHA or PfCoroninR100K/E107V-smHA parasites were purified by Percoll gradient centrifugation. Various age groups of parasites, as specified in the results section, were utilized for U-ExM. The samples were treated with pre-warmed 4% paraformaldehyde-0.1% glutaraldehyde in PBS for 20 min at 37 °C and prepared for U-ExM22,23. The following antibodies were employed for visualization: rat anti-HA for PfCoronin-smHA (1:25; Sigma Cat. No. 11867423001), Sytox Deep Red for DNA (1:1000; ThermoFisher Cat. No. S11380), rabbit anti-aldolase as a marker for parasite cytoplasm (1:2000; Abcam Cat. No. ab207494), Streptavidin-488 for parasites containing internalized biotin-dextran (1:250; Thermo Fisher Cat. No. S11223), and Alexa Fluor 405-conjugated NHS ester for protein density (1:200; ThermoFisher Cat. No. A30000). All secondary antibodies (anti-rat IgG Alexa fluor 488 Thermo Fisher Cat. No. A11006, anti-rabbit IgG Alexa fluor 555 Thermo Fisher Cat. No. A21428) were diluted 1:500 in PBS. Statistical analysis All experiments were performed with at least three independent biological replicates unless stated otherwise. For volcano plots of proteins from PfCoronin co‑immunoprecipitations, p-values were computed using unpaired two‑sided t‑tests. Protein quantifications (immunoblots) were compared using paired two‑sided t‑tests. Ring‑stage survival assay (RSA) data were compared using unpaired two‑sided t‑tests with Welch’s correction. Uptake of host cell contents (endocytosis assay) was compared using unpaired two‑sided non‑parametric Mann–Whitney tests. The presence or absence of cup‑shaped morphology in WT and mutant parasites was assessed using Fisher’s exact test (Baptista–Pike method). Cell‑cycle progression data were analyzed using unpaired two‑sided t‑tests with Welch’s correction and Holm–Šídák multiple‑comparison correction for comparisons at individual time points, and additionally using mixed‑effects models with genotype and time as fixed effects and biological replicate as a random effect. Competition assay data were analyzed using paired two‑sided t‑tests comparing allele frequencies at matched time points. All statistics were calculated using GraphPad Prism version 10.4.0 (GraphPad Software). No statistical methods were used to predetermine sample sizes. Researchers were blinded for analysis of the endocytosis assay (uptake of host cell contents) and for all RSA slide counts. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Supplementary information Description of Additional Supplementary Files Supplementary Data 1 Supplementary Data 2 Supplementary Data 3 Supplementary Data 4 Reporting Summary Transparent Peer Review file Supplementary information Description of Additional Supplementary Files Supplementary Data 1 Supplementary Data 2 Supplementary Data 3 Supplementary Data 4 Reporting Summary Transparent Peer Review file Source data Source Data Source Data